Clinical Trials List
2021-10-01 - 2025-04-18
Phase III
Not yet recruiting5
Terminated5
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 劉震鐘 未分科
- YI-LING CHIEN Division of Psychiatry
- 謝明憲 Division of Psychiatry
- Chen-Chung Liu Division of Psychiatry
- Tzung-Jeng Hwang Division of Psychiatry
- 劉耀臨 Division of Ophthalmology
- CHIH-MIN LIU Division of Psychiatry
- YI-TING LIN Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Mao-Hsiu Hua Division of Psychiatry
- 林式穀 Division of Psychiatry
- 沈信衡 Division of Psychiatry
- 周亞欣 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YI-CHUN LIU Division of Psychiatry
- 許文郁 Division of Psychiatry
- 陳力源 Division of Psychiatry
- 陳昱安 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林哲名 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃郁絜 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
1400 participants
